CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 10 years ago You may also like 55:52 Webinar: Edgewise — A Novel Approach Designed to Protect Muscle in Becker (May 2023) 2 years ago Research & Clinical Trial Webinars,Webinars 48:49 Webinar: Dyne Therapeutics — Advancing FORCE in the Pursuit of Therapies (April 2023) 2 years ago Research & Clinical Trial Webinars,Webinars 1:01:16 Connect With the Experts: Bone Health in Duchenne (April 2023) 2 years ago Care Webinars,Webinars 37:26 Webinar: Viltepso, An FDA-Approved Treatment for Patients Amenable to Exon 53 Skipping (March 2023) 2 years ago Research & Clinical Trial Webinars,Webinars 54:44 Webinar: Avidity Biosciences – EXPLORE44 Clinical Trial Investigating AOC 1044 (February 2023) 2 years ago Research & Clinical Trial Webinars,Webinars 1:17:46 Webinar: Capricor Data Update From Ongoing HOPE-2 Open Label Extension Trial (January 2023) 2 years ago Research & Clinical Trial Webinars,Webinars 1:09:29 Connect with the Experts: Pulmonary Management in the Winter Season 2 years ago Care Webinars,Webinars 45:50 Webinar: A Conversation with PTC Therapeutics (December 2022) 2 years ago Research & Clinical Trial Webinars,Webinars «1…34567…25»Page 5 of 25
by: Parent Project Muscular Dystrophy
